Skip to main content

ScienceDex / Researcher record

Gordon, Michael Scott

From the FY2022 NIH awards this investigator leads as contact PI. The department is the award's.

FY2022 NIH rank #1,368
  • Rising Star
  • Sustained Excellence
  • R01 Holder
  • Long-Funded
  • Top 10% Funded

NIH Funding · FY2022

$3.5M
Full award amounts, FY2022
3
Records listing this PI
#1,368
By linked amount among FY2022 PIs
2010
ScienceDex PI coverage

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

Linked awards ($M)Award-linked rank
View yearly values
Award-linked funding and rank by fiscal year
Fiscal yearLinked awardsRecordsRank
2010$738,6721#11,677
2011$731,6411#10,087
2012$885,6172#8,040
2013$654,6741#10,981
2014$400,6071#18,623
2015$451,5683#16,958
2016$644,9961#12,190
2017$631,3031#12,977
2018$1,617,7013#3,873
2019$2,927,4643#1,648
2020$1,266,2652#1,952
2021$2,900,9423#1,816
2022$3,475,3273#1,368
2023$562,6651#21,773

Award activity

Awards through the years

NIH award records listing this researcher in each fiscal year.

  1. FY20101 record
  2. FY20111 record
  3. FY20122 records
  4. FY20131 record
  5. FY20141 record
  6. FY20153 records
  7. FY20161 record
  8. FY20171 record
  9. FY20183 records
  10. FY20193 records
  11. FY20202 records
  12. FY20213 records
  13. FY2022 · selected3 records
  14. FY20231 record

Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Gordon, Michael Scott. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2022 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets About this stat →

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Publications

Loading publications…

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID unavailableSearch this ID in NIH RePORTER
ORCID iD
No ORCID iD on recordA researcher can add one by claiming this profile.
ScienceDex PI coverage
FY2010 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.

FY2022 award records by amount

NIH award records listing Gordon, Michael Scott as a PI. Multi-PI records show the full award amount for context.

  • 5UG1DA050077-04UG1Contact PI
    A comparative effectiveness trial of extended release naltrexone versus extended-release buprenorphine with individuals leaving jail
    $2.2M
    award amount
  • 3UG1DA050077-04S1UG1Contact PI
    A comparison of Sublingual and Extended-Release Buprenorphine for Individuals Leaving Jail
    $678.6K
    award amount
  • 5R01DA043476-04R01Contact PI
    Buprenorphine for probationers and parolees: Bridging the gap into treatment
    $627.4K
    award amount

Award organization

Organizations that administered FY2022 awards listing Gordon, Michael Scott as a PI.

FY2022 award administered by Friends Research Institute, Inc. (MD).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2010
    First NIH Award
    Friends Research Institute, Inc.
  2. 2010
    $500K Cumulative Funding
  3. 2011
    $1M Cumulative Funding
  4. 2012
    $2M Cumulative Funding
  5. 2012
    Entered Top 50% Nationally
    Ranked #8040
  6. 2014
    R01 Grant Holder
  7. 2017
    $5M Cumulative Funding
  8. 2018
    Entered Top 25% Nationally
    Ranked #3873
  9. 2019
    Entered Top 10% Nationally
    Ranked #1648
  10. 2020
    $10M Cumulative Funding